Form 8-K - Current report:
SEC Accession No. 0001171843-19-001442
Filing Date
2019-03-04
Accepted
2019-03-04 07:28:38
Documents
3
Period of Report
2019-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_030419.htm 8-K 17885
2 PRESS RELEASE exh_991.htm EX-99.1 70671
3 PRESS RELEASE exh_992.htm EX-99.2 9543
  Complete submission text file 0001171843-19-001442.txt   99303
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 19651870
SIC: 2836 Biological Products, (No Diagnostic Substances)